STK414603

CAS No. 796115-75-8

STK414603( —— )

Catalog No. M28974 CAS No. 796115-75-8

STK414603 is a heterocyclic acetamide derivative with potential analgesic, anti-inflammatory, and antimicrobial activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 59 Get Quote
10MG 78 Get Quote
25MG 123 Get Quote
50MG 178 Get Quote
100MG 261 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    STK414603
  • Note
    Research use only, not for human use.
  • Brief Description
    STK414603 is a heterocyclic acetamide derivative with potential analgesic, anti-inflammatory, and antimicrobial activities.
  • Description
    STK414603 is a heterocyclic acetamide derivative with potential analgesic, anti-inflammatory, and antimicrobial activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Aromatase|CYP19
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    796115-75-8
  • Formula Weight
    252.72
  • Molecular Formula
    C11H9ClN2OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(Cc(cccc1)c1Cl)Nc1nccs1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.M Kudoh, et al. The potent and selective inhibition of estrogen production by non-steroidal aromatase inhibitor, YM511. J Steroid Biochem Mol Biol. 1995 Sep;54(5-6):265-71.
molnova catalog
related products
  • GAD65 (78–97)

    GAD65 (78–97)

  • Perseitol

    Perseitol is a sugar that is specific to avocado honey. Perseitol have recently been reported as candidate biomarkers for avocado intake.

  • Stressin I

    Potent and selective corticotropin releasing factor receptor-1 (CRF1) agonist (Ki values are 1.5 and 224 nM for CRF1 and CRF2 receptors respectively). Increases ACTH levels and increases faecal pellet output in vivo following i.p. administration.